BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
BenzingaBenzinga Korea 한국
수요일, 9월 30

Medpace Holdings Inc

MEDPNASDAQ
Trade with Public
Trade with Public
$623.08
0.970.16%
마지막 업데이트: Sep 30, 11:28 AM
개요뉴스실적 전망목표가재무심리지분 현황비교옵션주식 보고서

Medpace Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medpace Holdings (MEDP).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

4Buy
9Hold
1Sell
Consensus RatingHold# Analysts14Avg. Consensus PT$510Upside to Avg. PT-18.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →
DateFirmAnalystActionRating ChangePrice Target
Jul 24, 2026MizuhoAnn HynesPT RaiseOutperform$586→$665
Jul 24, 2026BMO CapitalSean DodgePT RaiseMarket Perform$400→$600
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.
Benzinga Newsdesk

PRO
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609

Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692

RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
Benzinga Newsdesk

PRO
Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624

Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $586

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $495 to $586.
Benzinga Newsdesk

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

시장 데이터 제공 Benzinga API

BenzingaBenzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved